A simple tweak in available vial sizes of the breakthrough Alzheimer's drug Leqembi could save Medicare hundreds of millions of dollars each year, a new analysis claims.

New research suggests that Medicare could save up to 74 percent of the money lost from discarded Alzheimer's drug Leqembi or lecanemab by simply introducing a new vial size that would reduce the amount of unused medication thrown away.